Search for: "Schering Corp"
Results 241 - 251
of 251
Sorted by Relevance
|
Sort by Date
28 Oct 2011, 7:00 am
Schering Corp., 606 A.2d 1140, 1148, 1150 (N.J. [read post]
3 Apr 2009, 7:23 pm
Cinram International Inc (Property, intangible) USPTO rules for Smith & Nephew in suture patent fight with Arthrex (Law360) USPTO issues mixed decision in re-examination of patent at the centre of battle between Widevine and Verimatrix (Law360) Supreme Court asked to expand defences to patent infringement: IGT v Aristocrat Tech of Australia (on petition for certiorari) (Patently-O) CAFC to hear oral argument in Erbe Elektromedizin GmbH v ITC on 3 April (ITC 337 Law Blog) Tafas v Doll… [read post]
21 Apr 2010, 12:08 pm
” Schering-Plough Healthcare Products, Inc. v. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
20 May 2010, 12:46 pm
” In re Schering-Plough Corp. [read post]
22 Feb 2008, 1:30 pm
In a crushing blow to consumers, on Thursday, February 21st, the United States Supreme Court again sided with big pharmaceutical medical device makers. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
22 Oct 2009, 6:02 am
(Editor's Note: This post is based on a Gibson, Dunn & Crutcher LLP memorandum by Amy Goodman and Gillian McPhee.) [read post]
17 Jun 2010, 6:47 am
Jirak v. [read post]
16 Oct 2009, 3:18 pm
Dietary supplement claims must be substantiated by scientific evidence, the FDA has guidance for industry about this. [read post]
